0001562180-15-000578.txt : 20150721 0001562180-15-000578.hdr.sgml : 20150721 20150721174552 ACCESSION NUMBER: 0001562180-15-000578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150720 FILED AS OF DATE: 20150721 DATE AS OF CHANGE: 20150721 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stambaugh James CENTRAL INDEX KEY: 0001614498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 15998595 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE STREET 2: C/O INTERSECT ENT, INC. CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2015-07-20 false 0001271214 Intersect ENT, Inc. XENT 0001614498 Stambaugh James C/O INTERSECT ENT, INC., 1555 ADAMS DR. MENLO PARK CA 94025 false true false false VP Clinical Affairs Common Stock 2015-07-20 4 M false 12000.00 0.48 A 12000.00 D Common Stock 2015-07-20 4 S false 12000.00 30.5174 D 0.00 D Stock Option (right to buy) 0.48 2015-07-20 4 M false 12000.00 0.00 D 2016-11-16 Common Stock 12000.00 27062.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $30.92, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning October 23, 2007. /s/ Jeryl L. Hilleman, Attorney-in-Fact for James W. Stambaugh 2015-07-21